Karin Kroeze‐Jansema

The CHEK2*1100delC variant acts as a breast cancer risk modifier in non-BRCA1/BRCA2 multiple-case families.

Rogier A. Oldenburg, Karin Kroeze‐Jansema, Hans Morreau et al. · PubMed · 2003 · 116 citations

Tumor Biology, Non-brca1/brca2 Multiple-case Families, Variant Acts +15

Evaluation of linkage of breast cancer to the putative BRCA3 locus on chromosome 13q21 in 128 multiple case families from the Breast Cancer Linkage Consortium

Deborah J. Thompson, Csilla I. Szabo, Jon Mangion et al. · Proceedings of the National Academy of Sciences · 2002 · 92 citations · Full text

Clinical correlates of low-risk variants in FGFR2, TNRC9, MAP3K1, LSP1 and 8q24 in a Dutch cohort of incident breast cancer cases

Petra E.A. Huijts, Maaike P.G. Vreeswijk, Karin Kroeze‐Jansema et al. · Breast Cancer Research · 2007 · 83 citations · Full text

Characterization of Familial Non-<i>BRCA1/2</i>Breast Tumors by Loss of Heterozygosity and Immunophenotyping

Rogier A. Oldenburg, Karin Kroeze‐Jansema, Hanne Meijers-Heijboer et al. · Clinical Cancer Research · 2006 · 28 citations · Full text

Genome‐wide linkage scan in Dutch hereditary non‐BRCA1/2 breast cancer families identifies 9q21‐22 as a putative breast cancer susceptibility locus

Rogier A. Oldenburg, Karin Kroeze‐Jansema, Jeanine J. Houwing‐Duistermaat et al. · Genes Chromosomes and Cancer · 2008 · 17 citations